Authors:
, , , , , , and
Author:
Beniam Ghebremedhin MD, MSc
Beniam Ghebremedhin MD, MSc
Faculty of Health, University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, Witten, 58448, Germany
HELIOS Clinic Wuppertal, Institute of Medical Laboratory Diagnostics, Heusnerstr. 40, Wuppertal, 42283, Germany
Search for other papers by Beniam Ghebremedhin MD, MSc in
Current site
Google Scholar
PubMed
HELIOS Clinic Wuppertal, Institute of Medical Laboratory Diagnostics, Heusnerstr. 40, Wuppertal, 42283, Germany
Search for other papers by Beniam Ghebremedhin MD, MSc in
Current site
Google Scholar
PubMed
Abstract
The aim of this review is to describe the biology of human adenovirus (HAdV), the clinical and epidemiological characteristics of adenoviral epidemic keratoconjunctivitis and to present a practical update on its diagnosis, treatment, and prophylaxis. There are two well-defined adenoviral keratoconjunctivitis clinical syndromes: epidemic keratoconjunctivitis (EKC) and pharyngoconjunctival fever (PCF), which are caused by different HAdV serotypes. The exact incidence of adenoviral conjunctivitis is still poorly known. However, cases are more frequent during warmer months. The virus is endemic in the general population, and frequently causes severe disease in immunocompromised patients, especially the pediatric patients. Contagion is possible through direct contact or fomites, and the virus is extremely resistant to different physical and chemical agents. The clinical signs or symptoms of conjunctival infection are similar to any other conjunctivitis, with a higher incidence of pseudomembranes. In the cornea, adenoviral infection may lead to keratitis nummularis. Diagnosis is mainly clinical, but its etiology can be confirmed using cell cultures, antigen detection, polymerase chain reaction or immunochromatography. Multiple treatments have been tried for this disease, but none of them seem to be completely effective. Prevention is the most reliable and recommended strategy to control this contagious infection.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. G.H. Huang W.B. Xu 2013 Recent advance in new types of human adenovirus Bing Du Xue Bao 29 342 348.
-
2. S.P. Buckwalter R. Teo M.J. Espy L.M. Sloan T.F. Smith B.S. Pritt 2012 Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources J Clin Microbiol 50 766 771.
-
3. Human Adenovirus Working Group. Human Adenovirus Genotype Classification. (http://hadvwg.gmu.edu/) (accessed Dec. 7th, 2013}.
-
4. W.P. Rowe R.J. Huebner L.K. Gilmore R.H. Parrot T.G. Ward 1953 Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture Proc Soc Exp Biol Med 84 570 573.
-
5. M.S. Jones B. Harrach R.D. Ganac M.M. Gozum W.P. Dela Cruz B. Riedel C. Pan E.L. Delwart D.P. Schnurr 2007 New adenovirus species found in a patient presenting with gastroenteritis J. Virol 81 5978 5984.
-
6. I. Madisch S. Hofmayer C. Moritz A. Grintzalis J. Hainmueller P. Pring-Akerblom A. Heim 2007 Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design J Virol 81 8270 8281.
-
7. K. Aoki H. Ishiko T. Konno Y. Shimada A. Hayashi H. Kaneko T. Ohguchi Y. Tagawa S. Ohno S. Yamazaki 2008 Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirus J Clin Microbiol 46 3259 3269.
-
8. H. Kaneko K. Aoki S. Ishida S. Ohno N. Kitaichi 2011 Recombinant analysis of intermediate human adenovirus type 53 in Japan by complete genome sequence J. Gen Virol 92 1251 1259.
-
9. H. Kaneko K. Aoki S. Ohno H. Ishiko T. Fujimoto M. Kikuchi 2011 Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan J Clin Microbiol 49 484 490.
-
10. H. Kaneko T. Suzutani K. Aoki N. Kitaichi S. Ishida 2011 Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan Br J Ophthalmol 95 32 36.
-
11. C.M. Robinson G. Singh C. Henquell M.P. Walsh H. Peigue-Lafeuille D. Seto 2011 Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality Virology 409 141 147.
-
12. D. Seto J. Chodosh J.R. Brister M.S. Jones 2011 Using the whole genome sequence to characterize and name human adenoviruses J. Virol. 85 5701 5702.
-
13. M.P. Walsh M.P. Walsh A. Chintakuntlawar C.M. Robinson I. Madisch B. Harrach 2009 Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis PLoS One 4 5635.
-
14. M.P. Walsh J. Seto M.S. Jones J. Chodosh W. Xu D. Seto 2010 Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen J Clin Microbiol 48 991 993.
-
15. C. Kohl M.Z. Vidovszky K. Mühldorfer P.W. Dabrowski A. Radonic A. Nitsche 2012 Genome analysis of bat adenovirus 2: indications of interspecies transmission J Virol 86 1888 1892.
-
16. D. Wevers S. Metzger F. Babweteera M. Bieberbach 2011 Novel adenoviruses in wild primates: a high level of genetic diversity and evidence of zoonotic transmissions J Virol 85 10774 10784.
-
17. T. Walls A.G. Shankar D. Shingadia 2003 Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients Lancet Infect Dis 3 79 86.
-
18. N. Singh-Naz W. Rodriguez 1996 Adenoviral infections in children Adv Pediatr Infect Dis 11 365 388.
-
19. J. Mahr L. Gooding 1999 Immune evasion by adenoviruses Immunol Rev 168 121 130.
-
20. P.F. Lewis M.A. Schmidt X. Lu D.D. Erdman M. Campbell 2009 A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14 J Infect Dis 199 1427 1434.
-
21. S.Y. Chang C.N. Lee P.H. Lin 2008 A community derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005 J Med Virol 80 102 112.
-
22. B. Harrach M. Benkö G. Both M. Brown A. Davis M. Echavarría M. Hess M. Jones A. Kajon H. Lahmkuhl V. Mautner S. Mittal G. Wadell 2011 Family Adenoviridae K. A A. M C. E L. E Virus taxonomy: classification and nomenclature of viruses Ninth report of the International Committee on Taxonomy of Viruses. Elsevier, San Diego, CA 95 111.
-
23. A.G. Maranhao C.C. Soares M.C. Albuquerque N. Santos 2009 Molecular epidemiology of adenovirus conjunctivitis in Rio de Janeiro, Brazil, between 2004 and 2007 Rev Inst Med Trop Sao Paulo 51 227 229.
-
24. R.P. Sambursky N. Fram E.J. Cohen 2007 The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room Optometry 78 236 239.
-
25. E. Jawetz S. Kimura A.N. Nicholas P. Thygeson L. Hanna 1955 New type of APC virus from epidemic keratoconjunctivitis Science 122 1190 1191.
-
26. P.D. Swenson G. Wadell A. Allard J.C. Hierholzer 2003 Adenoviruses Manual of Clinical Microbiology, 8 ed 2 ASM Press Washington, DC.
-
27. J.C. De Jong A.G. Wermenbol M.W. Verweij-Uijterwaal K.W. Slaterus P. Wertheim-Van Dillen G.J. Van Doornum 1999 Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively J Clin Microbiol 37 3940 3945.
-
28. J.J. Trentin Y. Yabe G. Taylor 1962 The quest for human cancer viruses Science 137 835 841.
-
29. Y. Yabe L. Samper E. Bryan G. Taylor J.J. Trentin 1964 Oncogenic effect of human adenovirus type 12 in mice Science 143 46 47.
-
30. Y. Yabe J.J. Trentin G. Taylor 1962 Cancer induction in hamsters by human type 12 adenovirus. Effect of age and of virus dose Proc Soc Exp Biol Med 111 343 344.
-
31. P.H. Gallimore 1972 Tumour production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2 J Gen Virol 16 99 102.
-
32. P.H. Gallimore J.K. McDougall L.B. Chen 1977 In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice Cell 10 669 678.
-
33. A.J. Van der Eb C. Mulder F.L. Graham A. Houweling 1977 Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA Gene 2 115 132.
-
34. R. Feigin J. Cherry 1998 Textbook of paediatric infectious diseases 4th ed WB Saunders Company Philadelphia.
-
35. J. Hierholzer 1992 Adenovirus in the immunocompromised host Clin Microbiol 5 262 274.
-
36. D. Erdman W. Xu S. Gerber 2002 Molecular epidemiology of adenovirus type 7 in the United States, 1966–2000 Emerg Infect Dis 8 269 277.
-
37. B. Meyer-Rüsenberg U. Loderstädt G. Richard P.M. Kaulfers C. Gesser 2011 Epidemic Keratoconjunctivitis — the current situation and recommendations for prevention and treatment Dtsch Ärztebl Int 108 475 480.
-
38. H. Ishiko Y. Shimada T. Konno A. Hayashi T. Ohguchi Y. Tagawa K. Aoki S. Ohno S. Yamazaki 2008 Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis J Clin Microbiol 46 2002 2008.
-
39. H. Kaneko T. Iida H. Ishiko T. Ohguchi T. Ariga Y. Tagawa K. Aoki S. Ohno T. Suzutani 2009 Analysis of the complete genome sequence of epidemic keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a novel serotype J Gen Virol 90 1471 1476.
-
40. K. Aoki H. Ishiko T. Konno Y. Shimada A. Hayashi H. Kaneko T. Ohguchi Y. Tagawa S. Ohno S. Yamazaki 2008 Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirus J Clin Microbiol 46 3259 3269.
-
41. W.J. Martone J.C. Hierholzer R.A. Keenlyside D.W. Fraser L.J. D'Angelo K.G. Winkler 1980 An outbreak of adenovirus type 3 disease at a private recreation center swimming pool Am J Epidemiol 111 229 327.
-
42. L.J. D'Angelo J.C. Hierholzer R.A. Keenlyside L.J. Anderson W.J. Martone 1979 Pharyngoconjunctival fever caused by adenovirus type 4: Report of a swimming pool-related outbreak with recovery of virus from pool water J Infect Dis 140 42 47.
-
43. B. Guyer D.M. O'Day J.C. Hierholzer W. Schaffner 1975 Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection J Infect Dis 132 142 150.
-
44. R.A. Keenlyside J.C. Hierholzer L.J. D'Angelo 1983 Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist office J Infect Dis 147 191 198.
-
45. J. Hillenkamp T. Reinhard R.S. Ross 2001 Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study Arch Ophthalmol 119 1487 1491.
-
46. J.J. González-López R. Morcillo-Laiz F.J. Muñoz-Negrete 2013 Adenoviral keratoconjunctivitis: an update Arch Soc Esp Oftalmol 88 108 115.
-
47. A. Schrauder D. Altmann G. Laude H. Claus K. Wegner R. Köhler H. Habicht-Thomas G. Krause 2006 Epidemic conjunctivitis in Germany, 2004 Euro Surveill 11 185 187.
-
48. C. Adlhoch I. Schöneberg G. Fell D. Brandau J. Benzler 2010 Increasing case numbers of adenovirus conjunctivitis in Germany, 2010 Euro Surveill 15 45 19707.
-
49. T. Ariga Y. Shimada K. Shiratori K. Ohgami 2005 Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years J Clin Microbiol 43 726 732.
-
50. K. Aoki N. Kanazono K. Ishi K. Kato H. Ohtsuka 1985 Clinicoepidemiological study of keratoconjunctivitis due to adenovirus type 37 (Ad 37) in Sapporo, Japan Nihon Ganka Gakkai Zasshi 89 294 298.
-
51. S. Yamadera K. Yamashita M. Akatsuka N. Kato M. Tokunaga I. Sakae 2000 Adenovirus type 7 outbreaks in Japan in 1998 Jpn J Infect Dis 53 22 23.
-
52. R. Kimura H. Migita K. Kadonosono E. Uchio 2009 Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis Acta Ophthalmol 87 44 47.
-
53. S.C. Kuo S.C. Shen S.W. Chang S.C. Huang C.H. Hsiao 2008 Corneal superinfection in acute viral conjunctivitis in young children J Pediatr Ophthalmol Strabismus 45 374 376.
-
54. B. Aronson S. Aronson G. Sobel D. Walker 1956 Pharyngoconjunctival fever; report of an epidemic outbreak AMA J Dis Child 92 596 612.
-
55. W. Wold T. Hermiston A. Tollefson 1994 Adenoviral proteins that subvert host defences Trends Microbiol 2 437 443.
-
56. L.R. Gooding W.S. Wold 1990 Molecular mechanisms by which adenoviruses counteract antiviral immune mechanisms Crit Rev Immunol 10 53 71.
-
57. G.A. Prince D.D. Porter A.B. Jenson R.L. Horswood R.M. Chanock H.S. Ginsberg 1993 Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus) J Virol 67 101 111.
-
58. P. Flomenberg V. Piaskowski R. Truitt J. Casper 1995 Characterisation of human proliferative T cell responses to adenovirus J Infect Dis 171 1090 1096.
-
59. R. Sambursky S. Tauber F. Schirra K. Kozich R. Davidson E.J. Cohen 2006 The RPS adeno detector for diagnosing adenoviral conjunctivitis Ophthalmology 113 1758 1764.
-
60. S. Hiroi M. Izumi K. Takahashi S. Morikawa T. Kase 2012 Isolation and characterization of a novel recombinant human adenovirus species D J Med Microbiol 61 1097 1102.
-
61. A.K. Adhikary H. Ushijima T. Fujimoto 2012 Human adenovirus type 8 genome typing J Med Microbiol 61 1491 1503.
-
62. A. Heim C. Ebnet G. Harste P. Pring-Akerblom 2003 Rapid and quantitative detection of human adenovirus DNA by realtime PCR J Med Virol 70 228 239.
-
63. E.G. Romanowski L.A. Roba L. Wiley T. Araullo-Cruz Y.J. Gordon 1996 The effects of corticosteroids of adenoviral replication Arch Ophthalmol 114 581 585.
-
64. E.G. Romanowski K.A. Yates Y.J. Gordon 2001 Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit Cornea 20 657 660.
-
65. E.G. Romanowski K.A. Yates Y.J. Gordon 2001 Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model Antiviral Res 52 275 280.
-
66. E.G. Romanowski K.A. Yates Y.J. Gordon 2002 Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model Cornea 21 289 291.
-
67. E.G. Romanowski K.A. Yates Y.J. Gordon 2009 The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections Invest Ophthalmol Vis Sci 50 5295 5299.
-
68. J. Hillenkamp T. Reinhard R.S. Ross D. Bohringer O. Cartsburg M. Roggendorf 2002 The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study Ophthalmology 109 845 850.
-
69. B. Teuchner M. Nagl A. Schidlbauer H. Ishiko E. Dragosits H. Ulmer 2005 Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis — a double-blind, randomized, phase-2 clinical trial J Ocul Pharmacol Ther 21 157 165.
-
70. R. Sundmacher R. Wigand K. Cantell 1982 The value of exogenous interferon in adenovirus keratoconjunctivitis Graefes Arch Clin Exp Ophthalmol 218 139 140.
-
71. I. Maîchuk E.V. Iani 1999 Locferon: new eyedrops for treatment eye adenoviral diseases Vestn Oftalmol 115 32 33.
-
72. E.S. Yamazaki C.A. Ferraz R.M. Hazarbassanov N. Allemann M. Campos 2011 Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis Am J Ophthalmol 151 35 43.
-
73. J.S. Pelletier K. Stewart W. Trattler D.C. Ritterband S. Braverman C.M. Samson 2009 A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis Adv Ther 26 776 783.
-
74. E. Levinger A. Slomovic W. Sansanayudh I. Bahar A.R. Slomovic 2010 Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis Cornea 29 638 640.
-
75. S.J. Isenberg L. Apt M. Valenton M. Del Signore L. Cubillan M.A. Labrador 2002 A controlled trial of povidone-iodine to treat infectious conjunctivitis in children Am J Ophthalmol 134 681 688.
-
76. E. Ford K.E. Nelson D. Warren 1987 Epidemiology of epidemic keratoconjunctivitis Epidemiol Rev 9 244 261.
-
77. R.C. Nauheim E.G. Romanowski T. Araullo-Cruz R.P. Kowalski P.W. Turgeon S.S. Stopak 1990 Prolonged recovery of desiccated adenovirus 19 from various surfaces Ophthalmology 97 1450 1453.
-
78. J.D. Gottsch 1996 Surveillance and control of epidemic keratoconjunctivitis Trans Am Ophthalmol Soc 94 539 587.
-
79. J.K.G. Dart A.N. El-Amir T. Maddison P. Desai S. Verma A. Hughes 2009 Identification and control of nosocomial adenovirus keratoconjunctivitis in an ophthalmic department Br J Ophthalmol 93 18 20.
-
80. S.S. Seregin A. Amalfitano 2010 Improving adenovirus based gene transfer: strategies to accomplish immune evasion Viruses 2 2013 2036.
-
81. S.S. Ghosh P. Gopinath A. Ramesh 2006 Adenoviral vectors: a promising tool for gene therapy Appl Biochem Biotechnol 133 9 29.
-
82. K. Toth Wold WSM 2010 Increasing the efficacy of oncolytic adenovirus vectors Viruses 2 1844 1866.
Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de
Indexing and Abstracting Services:
- PubMed Central
- Scopus
- ESCI
- CABI
- CABELLS Journalytics
| 2023 | |
|---|---|
| Web of Science | |
| Total Cites WoS |
674 |
| Journal Impact Factor | 3.3 |
| Rank by Impact Factor |
Q2 |
| Impact Factor without Journal Self Cites |
3.1 |
| 5 Year Impact Factor |
3.2 |
| Scimago | |
| Scimago H-index |
15 |
| Scimago Journal Rank |
0.601 |
| Scimago Quartile Score | Microbiology (medical) (Q2) Microbiology (Q3) Immunology and Allergy (Q3) Immunology (Q3) |
| Scopus | |
| Scopus Cite Score |
5.0 |
| Scopus CIte Score Rank |
Microbiology (medical) Q2 |
| Scopus SNIP |
0.832 |
| European Journal of Microbiology and Immunology | |
|---|---|
| Publication Model | Gold Open Access Online only |
| Submission Fee | none |
| Article Processing Charge | 600 EUR/article |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription Information | Gold Open Access |
| Purchase per Title | |
| European Journal of Microbiology and Immunology | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
2011 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Akadémiai Kiadó |
| Founder's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2062-509X (Print) |
| ISSN | 2062-8633 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Apr 2024 | 343 | 0 | 0 |
| May 2024 | 347 | 0 | 0 |
| Jun 2024 | 467 | 0 | 0 |
| Jul 2024 | 394 | 0 | 0 |
| Aug 2024 | 330 | 0 | 0 |
| Sep 2024 | 1294 | 0 | 0 |
| Oct 2024 | 327 | 0 | 0 |
Author:
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory